What M&A slowdown? Buyers circle GreenLight Biosciences, Egitis Therapeutics
Sanofi attempting to spin off consumer health unit in India
Illumina urges shareholders to reject Carl Icahn’s board nominees as proxy fight heats up
Major readouts on the horizon for small developers
*please scroll down for all the latest news*